Generate Biomedicines, Inc. SEC EDGAR Filings (CIK 0002100782)

SEC EDGAR filings, ownership reports, and insider transactions for Generate Biomedicines, Inc..

Symbol
GENB
Business address
101 South Street, Suite 900, Somerville, MA, 02143
State of incorporation
DE
Fiscal year end
31 December
Get insider transactions for this issuer
Generate Biomedicines, Inc. has filed 43 SEC EDGAR filings since 23 Dec 2025

Latest Filings

Recent SEC filings for Generate Biomedicines, Inc. including 3, 4, 8-K and more.

Form type Document Filing Description Filing date Reporting date File number(s)
3 Open 3 document View SEC filing for 3 3 12 Mar 2026 02 Mar 2026
4 Open 4 document View SEC filing for 4 4 06 Mar 2026 04 Mar 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
4 Open 4 document View SEC filing for 4 4 02 Mar 2026 26 Feb 2026
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 02 Mar 2026 26 Feb 2026 001-43165
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 27 Feb 2026 333-293898
424B4 Open 424B4 document View SEC filing for 424B4 424B4 27 Feb 2026 333-293204
EFFECT Open EFFECT document View SEC filing for EFFECT 26 Feb 2026 333-293204
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
3 Open 3 document View SEC filing for 3 3 26 Feb 2026 26 Feb 2026
CERT Open CERT document View SEC filing for CERT 26 Feb 2026 001-43165
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 24 Feb 2026 001-43165
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 23 Feb 2026 333-293204
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 13 Feb 2026 333-293204
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 04 Feb 2026 333-293204
DRS Open DRS document View SEC filing for DRS 23 Dec 2025 377-08875

About this filer

Generate Biomedicines, Inc. files with the SEC under CIK 0002100782. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages